Cargando…

Infliximab as rescue therapy in refractory Kawasaki disease

Detalles Bibliográficos
Autores principales:	Rodríguez-González, Moisés, Matamala-Morillo, Miguel A, Segado-Arenas, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2014
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959072/ https://www.ncbi.nlm.nih.gov/pubmed/24701096 http://dx.doi.org/10.4103/0974-2069.126578

Ejemplares similares

Infliximab as a rescue therapy in the management of refractory typical infantile Kawasaki disease
por: Venkatnarayanan, K., et al.
Publicado: (2020)

Infliximab Treatment for Refractory Kawasaki Disease in Korean Children
por: Song, Min Seob, et al.
Publicado: (2010)

Infliximab as an alternative therapy for refractory adult onset Kawasaki disease: A case report
por: Kawaguchi, Takeshi, et al.
Publicado: (2018)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
por: Fernández-Guerrero, Manuel L., et al.
Publicado: (2007)

Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report
por: Corrigan, Margaret, et al.
Publicado: (2019)

Henoch-Schönlein purpura associated with infliximab therapy for pediatric Crohn’s disease
por: Li, Xiaolu, et al.
Publicado: (2022)

Kawasaki or Kawasaki-like disease? A debate on COVID-19 infection in children
por: Hosseini, Mohammad-Salar
Publicado: (2021)

Diagnosing Incomplete Kawasaki Disease
por: Aljishi, Fatimah Mouayed, et al.
Publicado: (2018)

Role of percutaneous left stellate ganglion blockade (LSGB) as a rescue therapy in refractory ventricular tachycardia
por: Burra, Vijitha, et al.
Publicado: (2020)

Successful treatment of refractory Sneddon‐Wilkinson disease (subcorneal pustular dermatosis) with infliximab
por: Romagnuolo, Maurizio, et al.
Publicado: (2022)

Letter to the editor regarding “The efficacy and safety of infliximab and calcineurin inhibitors in steroid-refractory UC patients: A meta-analysis”
por: Zhu, Qingcheng, et al.
Publicado: (2022)

Kawasaki disease presenting atypically as meningoencephlitis
por: Bhardwaj, Parveen, et al.
Publicado: (2009)

Sensorineural hearing loss in Kawasaki disease
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2016)

Adipocytokine profile in children with Kawasaki disease
por: Joob, Beuy, et al.
Publicado: (2023)

A case of rectal ulcers during aspirin therapy in acute Kawasaki disease
por: Han, Yong, et al.
Publicado: (2020)

Kawasaki disease and general anaesthesia: The Know - Hows
por: Ponde, Vrushali C, et al.
Publicado: (2018)

Infliximab, Is It Really a New Horizon for the Treatment of Kawasaki Disease?
por: Eun, Lucy Youngmin
Publicado: (2019)

Inﬂiximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis
por: Miyata, Koichi, et al.
Publicado: (2023)

Recurrent refractory Kawasaki disease
por: Costa Reis, P, et al.
Publicado: (2011)

Symptomless Pulmonary Cryptococcosis in a Psoriatic Arthritis Patient during Infliximab Therapy
por: Yamada, Saori, et al.
Publicado: (2016)

Congestive Heart Failure – An Atypical Presentation of Kawasaki Disease
por: Sahoo, Sushama, et al.
Publicado: (2012)

Reply to the letter concerning Kawasaki disease and Covid-19
por: Loomba, Rohit S., et al.
Publicado: (2020)

Posterior Reversible Encephalopathy Syndrome in a Patient With Crohn’s Disease on Infliximab
por: Chow, Stephen, et al.
Publicado: (2016)

Outcome of Immediate Dose Optimization of Infliximab in Inflammatory Bowel Disease Patients
por: Bacsur, Péter, et al.
Publicado: (2021)

Demodicosis as an opportunistic infection in a patient with Crohn’s disease treated with infliximab
por: Niedźwiedź, Michał, et al.
Publicado: (2022)

Covid-19 and Kawasaki syndrome
por: Wiwanitkit, Viroj
Publicado: (2020)

The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis
por: Li, Dan, et al.
Publicado: (2021)

Coronavirus disease 2019, Kawasaki disease, and multisystem inflammatory syndrome in children
por: Bassareo, Pier Paolo, et al.
Publicado: (2020)

Epidemiologic trends in Kawasaki disease during coronavirus disease-19 in Singapore
por: Yung, Chee Fu, et al.
Publicado: (2020)

Pustulovesicular Skin Eruption as Presenting Feature of Incomplete Kawasaki Disease
por: Goyal, JP, et al.
Publicado: (2016)

COVID-19 and Kawasaki disease: an analysis using Google Trends
por: Dey, Mrinalini, et al.
Publicado: (2020)

Acute generalized exanthematous pustulosis as a manifestation of Kawasaki disease
por: Wu, Wen-Jie, et al.
Publicado: (2021)

Acute submandibular sialadenitis in a patient with Crohn's disease being treated with infliximab()
por: Blasco Patiño, Felipe, et al.
Publicado: (2021)

Reactivation of Bovine Tuberculosis in Patient Treated with Infliximab, Switzerland
por: Nager, Marina, et al.
Publicado: (2009)

A Case of Orange-Brown Chromonychia in a Patient with Kawasaki Disease
por: Na, Chan Ho, et al.
Publicado: (2014)

The Relationship Between Hematological Findings and Coronary Artery Aneurysm in Kawasaki Disease
por: Beken, Burçin, et al.
Publicado: (2014)

Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic
por: Springer, Steffen, et al.
Publicado: (2021)

Kawasaki disease and COVID-19; a pretext for a hot topic
por: Jafarpour, Shahin, et al.
Publicado: (2021)

Prevalence and characteristics of Kawasaki disease before and during the COVID-19 pandemic
por: Ono, Rintaro, et al.
Publicado: (2021)

Efficacy of infliximab in neuro-Behçet’s disease presenting with isolated longitudinally extensive transverse myelitis
por: Kuroda, Ryo, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_eu821pn3cu4vvdfoolqa8gmbm0